LPS Nephropathy in Mice Is Ameliorated by IL-2 Independently of Regulatory T Cells Activity

Immunosuppressive regulatory T cells (Tregs) have been hypothesized to exert a protective role in animal models of spontaneous (Buffalo/Mna) and/or drug induced (Adriamycin) nephrotic syndrome. In this study, we thought to define whether Tregs can modify the outcome of LPS nephropathy utilizing IL-2 as inducer of tissue and circulating Tregs. LPS (12 mg/Kg) was given as single shot in C57BL/6, p2rx7−/− and Foxp3EGFP; free IL-2 (18.000 U) or, in alternative, IL-2 coupled with JES6-1 mAb (IL-2/anti-IL-2) were injected before LPS. Peripheral and tissue Tregs/total CD4+ cell ratio, urinary parameters and renal histology were evaluated for 15 days. IL-2 administration to wild type mice had no effect on peripheral Tregs number, whereas a significant increase was induced by the IL-2/anti-IL-2 immunocomplex after 5 days. Spleen and lymph nodes Tregs were comparably increased. In p2rx7−/− mice, IL-2/anti-IL-2 treatment resulted in increase of peripheral Tregs but did not modify the spleen and lymph nodes quota. LPS induced comparable and transient proteinuria in both wild type and p2rx7−/− mice. Proteinuria was inhibited by co-infusion of human IL-2, with reduction at each phase of the disease (24 −48 and 72 hours) whereas IL-2/anti-IL-2 produced weaker effects. In all mice (wild type and p2rx7−/−) and irrespective of treatment (IL-2, IL-2/anti-IL-2), LPS was associated with progressive signs of renal pathologic involvement resulting in glomerulosclerosis. In conclusion, IL-2 plays a transient protective effect on proteinuria induced by LPS independent of circulating or tissue Tregs but does not modify the outcome of renal degenerative renal lesions.

[1]  L. Gesualdo,et al.  Novel INF2 mutations in an Italian cohort of patients with focal segmental glomerulosclerosis, renal failure and Charcot-Marie-Tooth neuropathy. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  J. Reiser,et al.  Abatacept in B7-1-positive proteinuric kidney disease. , 2014, The New England journal of medicine.

[3]  M. Arnaout,et al.  Abatacept in B7-1-positive proteinuric kidney disease. , 2013, The New England journal of medicine.

[4]  N. Yang,et al.  P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway. , 2013, Arthritis and rheumatism.

[5]  S. Menini,et al.  The purinergic 2X7 receptor participates in renal inflammation and injury induced by high‐fat diet: possible role of NLRP3 inflammasome activation , 2013, The Journal of pathology.

[6]  C. Ahn,et al.  IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. , 2013, Journal of the American Society of Nephrology : JASN.

[7]  H. Anders,et al.  The immune system and kidney disease: basic concepts and clinical implications , 2013, Nature Reviews Immunology.

[8]  A. Anarat,et al.  Circulating suPAR in two cohorts of primary FSGS. , 2012, Journal of the American Society of Nephrology : JASN.

[9]  E. Shevach.  Application of IL-2 therapy to target T regulatory cell function. , 2012, Trends in immunology.

[10]  J. Sprent,et al.  IL-2/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD. , 2012, Journal of the American Society of Nephrology : JASN.

[11]  U. Schenk,et al.  Purinergic P2X7 Receptor Drives T Cell Lineage Choice and Shapes Peripheral γδ Cells , 2012, The Journal of Immunology.

[12]  H. Chi,et al.  Regulation of TH17 cell differentiation by innate immune signals , 2012, Cellular and Molecular Immunology.

[13]  W. Couser.  Basic and translational concepts of immune-mediated glomerular diseases. , 2012, Journal of the American Society of Nephrology : JASN.

[14]  F. Carrat,et al.  Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. , 2011, The New England journal of medicine.

[15]  G. Ghiggeri,et al.  Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome , 2011, Clinical and experimental immunology.

[16]  T. Palomero,et al.  Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. , 2011, Kidney international.

[17]  E. Salido,et al.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis , 2011, Nature Medicine.

[18]  Fabio Grassi,et al.  ATP Inhibits the Generation and Function of Regulatory T Cells Through the Activation of Purinergic P2X Receptors , 2011, Science Signaling.

[19]  S. Sakaguchi,et al.  FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents. , 2011, Trends in pharmacological sciences.

[20]  M. Okusa,et al.  Dangers within: DAMP responses to damage and cell death in kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[21]  Grace Y Chen,et al.  Sterile inflammation: sensing and reacting to damage , 2010, Nature Reviews Immunology.

[22]  Hong Wang,et al.  Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. , 2010, Frontiers in bioscience.

[23]  M. Atkinson,et al.  T regulatory cell function in idiopathic minimal lesion nephrotic syndrome , 2009, Pediatric Nephrology.

[24]  J. Sprent,et al.  In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression , 2009, The Journal of experimental medicine.

[25]  T. Wynn,et al.  Suppression of Murine Allergic Airway Disease by IL-2:Anti-IL-2 Monoclonal Antibody-Induced Regulatory T Cells1 , 2008, The Journal of Immunology.

[26]  F. Scolari,et al.  Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. , 2007, Journal of the American Society of Nephrology : JASN.

[27]  F. Scolari,et al.  Repetitive Fragmentation Products of Albumin and α1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome , 2006 .

[28]  G. Ghiggeri,et al.  Characterization of oxidation end product of plasma albumin 'in vivo'. , 2006, Biochemical and biophysical research communications.

[29]  F. Di Virgilio,et al.  The P2X7 Receptor: A Key Player in IL-1 Processing and Release1 , 2006, The Journal of Immunology.

[30]  J. Sprent,et al.  Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes , 2006, Science.

[31]  D. Harris,et al.  Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin. , 2006, Journal of the American Society of Nephrology : JASN.

[32]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[33]  G. Ghiggeri,et al.  New Insights into the Pathogenesis and the Therapy of Recurrent Focal Glomerulosclerosis , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  R. Kalluri,et al.  Induction of B7-1 in podocytes is associated with nephrotic syndrome. , 2004, The Journal of clinical investigation.

[35]  B. Beutler,et al.  Innate immune sensing and its roots: the story of endotoxin , 2003, Nature Reviews Immunology.

[36]  J. Kaplan,et al.  Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis , 2000, Nature Genetics.

[37]  G. Ghiggeri,et al.  Cytotoxic effect of adriamycin and agarose-coupled adriamycin on glomerular epithelial cells: Role of free radicals , 1991, In Vitro Cellular & Developmental Biology - Animal.

[38]  A. Koyama,et al.  A glomerular permeability factor produced by human T cell hybridomas. , 1991, Kidney international.

[39]  B. Brenner,et al.  Molecular basis of proteinuria of glomerular origin. , 1978, The New England journal of medicine.

[40]  B. Brenner,et al.  Mechanics of glomerular ultrafiltration. , 1977, The New England journal of medicine.

[41]  R. Shalhoub.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function. , 1974, Lancet.

[42]  H. Rakugi,et al.  A Superagonistic Monoclonal Antibody for CD28 Ameliorates Crescentic Glomerulonephritis in Wistar-Kyoto Rats , 2011, Molecular medicine.

[43]  C. Usal,et al.  Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. , 2009, Journal of the American Society of Nephrology : JASN.

[44]  P. Carmeliet,et al.  Modification of kidney barrier function by the urokinase receptor , 2008, Nature Medicine.

[45]  R. Ravazzolo,et al.  Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  J. Kaplan,et al.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. , 2000, Nature genetics.

[47]  H. von der Maase,et al.  Renal haemodynamics, sodium and water reabsorption during continuous intravenous infusion of recombinant interleukin-2. , 1998, Clinical science.

[48]  G. Remuzzi,et al.  Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. , 1982, Laboratory investigation; a journal of technical methods and pathology.